IL18 and adult-onset Still disease: Given that IL-18BP is a target of miR-134; our results from the cell-based functional assay suggest that miR-134 may contribute to AOSD pathogenesis through the downregulation of IL-18BP expression and the subsequent elevation of free IL-18 levels.